Sarepta Therapeutics, Inc. — Director's Dealing 2021

Mar 6, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2021-02-19

Reporting Person: Brown Ryan Edward (SVP, General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4838	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$62.77	2028-02-28	Common Stock (23500)		Direct
Stock Option (right to buy)	$145.48	2029-03-04	Common Stock (2319)		Direct
Stock Option (right to buy)	$145.48	2029-03-04	Common Stock (1831)		Direct
Stock Option (right to buy)	$113.85	2029-05-31	Common Stock (1455)		Direct
Stock Option (right to buy)	$114.47	2030-02-28	Common Stock (717)		Direct
Stock Option (right to buy)	$114.47	2030-02-28	Common Stock (3433)		Direct

Footnotes

F1: Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter.